Mineralys Therapeutics, Inc. ($MLYS)
RA CAPITAL MANAGEMENT, L.P. โ Director
Shares
8,300
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 11, 2026
EPS:Est: -0.57
Feb 18, 2026
EPS:Est: -0.57
Transaction Details
| Insider | RA CAPITAL MANAGEMENT, L.P. |
|---|---|
| Title | Director |
| Transaction Date | Feb 19, 2026 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Indirect |
| Nature of Ownership | See Footnote |
| Filing Date | Feb 21, 2026 |
| Shares Purchased | 8,300 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 8,300 |
| Derivative | Derivative |
| Accession Number | 0001231919-26-000186 |
| Document | View SEC Filing |